Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract
- PMID: 8012413
- DOI: 10.1007/BF00182044
Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract
Abstract
The roles of glycosaminoglycans and proteoglycans in the physiology of the urinary tract are reviewed. The structures of proteoglycans and glycosaminoglycans are reviewed together with their role in control of epithelial differentiation through stromal-epithelial interactions and as modulators of cytokines. Heparan sulfate proteoglycans appear to be important in maintaining selectivity of the kidney tubular basement membrane, and the majority of the glycosaminoglycan found in the urine appears to come from the upper tract. Evidence suggesting that a dense layer of glycosaminoglycans on the urothelial surface is important to maintaining urothelial impermeability is reviewed and new data showing a high density of proteoglycans on the lumenal surface of the urothelium is presented. The role of this layer in maintaining antibacterial adherence and impermeability was discussed together with data suggesting that failure of this layer is an etiologic factor in interstitial cystitis. A model of the bladder surface is also presented to illustrate the role of proteoglycans and exogenous glycosaminoglycans in the defenses of normal bladder lumen and the failure of these defenses in the interstitial cystitis bladder.
Similar articles
-
A model for the function of glycosaminoglycans in the urinary tract.World J Urol. 1994;12(1):38-42. doi: 10.1007/BF00182049. World J Urol. 1994. PMID: 8012414
-
Glycosaminoglycans and proteoglycans in the urinary tract.World J Urol. 1994;12(1):2. doi: 10.1007/BF00182043. World J Urol. 1994. PMID: 8012412 No abstract available.
-
Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis.Urology. 2007 Apr;69(4 Suppl):17-23. doi: 10.1016/j.urology.2006.03.083. Urology. 2007. PMID: 17462475
-
GAGs and GAGs diseases: when pathophysiology supports the clinic.Urologia. 2013 Jul-Sep;80(3):173-8. doi: 10.5301/RU.2013.11500. Epub 2013 Sep 30. Urologia. 2013. PMID: 24526593 Review.
-
Glycosaminoglycans: how much do we know about their role in the bladder?Urologia. 2016 Jun 25;83 Suppl 1:11-4. doi: 10.5301/uro.5000184. Epub 2016 Jun 23. Urologia. 2016. PMID: 27405344 Review.
Cited by
-
The urothelium of a hibernator: the American black bear.Physiol Rep. 2015 Jun;3(6):e12429. doi: 10.14814/phy2.12429. Physiol Rep. 2015. PMID: 26109187 Free PMC article.
-
Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result.Int Neurourol J. 2015 Jun;19(2):85-9. doi: 10.5213/inj.2015.19.2.85. Epub 2015 Jun 29. Int Neurourol J. 2015. PMID: 26126437 Free PMC article.
-
Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis.Can Urol Assoc J. 2014 Sep;8(9-10):E610-4. doi: 10.5489/cuaj.2036. Can Urol Assoc J. 2014. PMID: 25295131 Free PMC article.
-
Urinary glycosaminoglycan excretion in patients with primary nocturnal enuresis.Ital J Pediatr. 2010 Feb 3;36:13. doi: 10.1186/1824-7288-36-13. Ital J Pediatr. 2010. PMID: 20181082 Free PMC article.
-
Extracorporeal shock wave lithotripsy and glycosaminoglycans in urine.Int Urol Nephrol. 1998;30(2):113-21. doi: 10.1007/BF02550563. Int Urol Nephrol. 1998. PMID: 9607878
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical